Trigonella foenum graecum · herb
Evidence tier: limited
A multi purpose seed traditionally used for blood sugar, lactation, and male vitality.
Two plausible routes. 4-hydroxyisoleucine is reported to stimulate insulin secretion and improve insulin sensitivity, and galactomannan, a viscous soluble fibre, slows carbohydrate absorption from the gut. The meta analysis result is what makes the mechanism interesting and unusable at the same time: whatever fenugreek is doing, it barely moves HbA1c on its own and moves it four times as far when an antidiabetic drug is already acting. That pattern is more consistent with fenugreek amplifying a drug than with fenugreek working as a standalone agent.
Limited, and the reason is not that the evidence is thin. It is that the evidence is real, and it is locked inside a population and a drug interaction that no consumer supplement can use. The best source is a 2023 systematic review and meta analysis of randomised controlled trials in TYPE 2 DIABETES AND PREDIABETES (Int J Mol Sci 2023, PMID 37762302): 10 studies, 706 participants. Fenugreek significantly reduced fasting blood glucose (mean difference 26.66 mg/dL lower, 95% CI 29.80 to 23.52) and HbA1c (mean difference 0.54% lower, 95% CI 0.80 to 0.29). Now the subgroup that decides everything. When fenugreek was COMBINED WITH AN ANTIDIABETIC MEDICINE, HbA1c fell by 0.97%. When fenugreek was taken ALONE, HbA1c fell by 0.23%, AND THAT WAS NOT STATISTICALLY SIGNIFICANT. So the effect is four times larger stacked on a drug, and on its own, in the pooled data, fenugreek does essentially nothing to HbA1c. That is a pharmacodynamic drug interaction finding wearing the clothes of an efficacy finding. And every participant had diagnosed type 2 diabetes or prediabetes. THE LACTATION CLAIM, which is fenugreek's single biggest commercial use, is both weak and contraindicated. MSK About Herbs says the 'evidence of its potential to stimulate lactation is limited' and that 'evidence is lacking to support this claim and side effects have been reported'. MSK simultaneously lists BREASTFEEDING UNDER DO NOT USE: 'You are pregnant or breastfeeding: Fenugreek has been linked to an increased risk of birth defects and its safety in amounts greater than typically found in food are unknown.' The world's best selling galactagogue is one that MSK tells breastfeeding women not to take. The testosterone claim rests on small trials and I could not substantiate it against a vetted source. Other MSK safety facts: fenugreek may potentiate WARFARIN (case reports, plus severe coagulation failure with excessive use), serotonin syndrome with sertraline, anaphylaxis, and it 'acts as an estrogenic receptor modulator and may increase growth of breast cancer cells' in laboratory work.
No regulator sets a dose. The pooled trials used widely varying preparations (seed powder, hydroalcoholic extract, soaked seed) at doses that are not comparable to one another, which is one reason the pooled estimates are heterogeneous. No standard supplemental range can be stated from a vetted source.
500 to 1000 mg standardised extract daily, or 5 to 10 g whole seeds soaked overnight. With meals.
Avoid in pregnancy (uterine stimulant). May lower blood sugar significantly.
Pregnancy: avoid
Breastfeeding: avoid
Active compounds: 4-hydroxyisoleucine, galactomannan, diosgenin, trigonelline
Remedies using Fenugreek · Browse by body system · Check it against what you take
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.